Lv3
240 积分 2024-05-09 加入
A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies
10小时前
待确认
Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210
12小时前
已完结
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy
23天前
已完结
Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments
1个月前
已完结
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
1个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
4个月前
已完结
Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition
7个月前
已完结
CHO DUKX cell lineages preadapted to growth in serum-free suspension culture enable rapid development of cell culture processes for the manufacture of recombinant proteins
7个月前
已完结
‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization
7个月前
已完结
皖公网安备34019202002308
